DOCSLIB.ORG

Upper Extremity Montana Utilization and Treatment Guidelines

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Upper Extremity Montana Utilization and Treatment Guidelines Upper Extremity Montana Utilization and Treatment Guidelines Effective July 1, 2011 to December 31, 2016 Presented by: State of Montana Department of Labor and Industry EMPLOYMENT RELATIONS DIVISION Copyright ©2011 - State of Montana 1 July 1, 2011 A. Table of Contents A. Table of Contents B. General Guideline Principles ………………………………………………………….. 4 C. Definitions and Mechanisms of Injury …………………………………………………. 7 D. Initial Diagnostic Procedures …………………………………………………………... 8 D1. History Taking and Physical Examination (Hx & PE) …………………………….. 8 D2. Laboratory Testing …………………………………………………………………. 16 D3. Medical Causation Assessment for Upper Extremity Conditions …………………..18 E. Follow-up Diagnostic Imaging and Testing Procedures ……………………………….. 35 F. Specific Cumulative Trauma Conditions Diagnosis, Testing and Treatment Procedures 42 F1. Aggravated Osteoarthritis ………………………………………………………….. 42 F2. De Quervain's Disease ………………………………………………………………47 F3. Epicondylitis - Lateral Epicondylalgia ……………………………………………... 49 F4. Epicondylitis - Medial (Epicondylalgia) …………………………………………… 55 F5. Extensor Tendon Disorders of the Wrist …………………………………………… 59 F6. Flexor Tendon Disorders of the Wrist ……………………………………………... 61 F7. Hand Arm Vibration Syndrome ……………………………………………………. 63 F8. Triangular Fibrocartilage Complex Tear (TFCC) ………………………………….. 65 F9. Trigger Finger ……………………………………………………………………… 68 F10. Thoracic Outlet Syndrome ………………………………………………………... 70 G. Specific Peripheral Nerve Diagnosis, Testing and Treatment Procedures …………….. 76 G1. Carpal Tunnel Syndrome …………………………………………………………... 76 G2. Cubital Tunnel Syndrome …………………………………………………………. 89 G3. Guyon Canal (Tunnel) Syndrome …………………………………………………. 92 G4. Posterior Interosseous Nerve Entrapment (PIN) ………………………………….. 94 G5. Pronator Syndrome ………………………………………………………………… 96 G6. Radial Nerve Entrapment at the Wrist …………………………………………….. 99 G7. Radial Tunnel Syndrome ………………………………………………………….. 101 H. Specific Musculoskeletal Disorders (MSDs) Diagnosis, Testing and Treatment Procedures …………………………………………………………………………………………….. 104 H1. Amputations and Indications for Replantation ……………………………………. 104 H2. Biceps Tendinosis/Tendinitis and tears/ruptures ………………………………….. 105 H3. Crush Injuries and Compartment Syndrome ……………………………………… 107 H4. Distal Forearm Fractures ………………………………………………………….. 109 H5. Distal Phalanx Fractures and Subungual Hematoma ……………………………… 113 H6. Elbow Contusion ……………………………………………………………………115 H7. Elbow Dislocation …………………………………………………………………. 116 H8. Elbow Fractures including non-displaced radial head fractures ……………………118 H9. Elbow Osteonecrosis [Avascular Necrosis (AVN)] ……………………………….. 120 H10. Elbow Pain, Non-specific ………………………………………………………… 122 H11. Elbow Sprain ………………………………………………………………………123 H12. Ganglion Cyst …………………………………………………………………….. 125 H13. Hand/Wrist/Forearm Pain - Non-specific ………………………………………… 127 H14. Human and Animal Bite Lacerations …………………………………………….. 129 H15. KienbÖck Disease …………………………………………………………………130 Copyright ©2011 - State of Montana 2 July 1, 2011 H16. Laceration Management ………………………………………………………….. 132 H17. Mallet Finger ………………………………………………………………………135 H18. Middle and Proximal Phalangeal and Metacarpal Fractures ………………………137 H19. Olecranon Bursitis …………………………………………………………………140 H20. Scaphoid Fracture ………………………………………………………………… 142 H21. Triceps Tendinosis/Tendinitis and Tears/Ruptures ………………………………. 145 H22. Wrist Sprains ………………………………………………………………………145 I. Therapeutic Procedures - Non-operative ………………………………………………... 148 I1. Acupuncture ………………………………………………………………………….148 I2. Biofeedback …………………………………………………………………………. 150 I3. Injections - Therapeutic ………………………………………………………………150 I4. Jobsite Alterations ……………………………………………………………………154 I5. Medications and Medical Management ……………………………………………... 158 I6. Occupational Rehabilitation Programs ……………………………………………… 163 I7. Patient Education ……………………………………………………………………. 165 I8. Personality/Psychological/Psychosocial Intervention ………………………………..165 I9. Return to Work ……………………………………………………………………….166 I10. Sleep Disturbances ………………………………………………………………… 167 I11. Therapy - Active …………………………………………………………………… 168 I12. Therapy - Passive …………………………………………………………………...170 I13. Restriction of Activities ……………………………………………………………. 176 I14. Vocational Rehabilitation ………………………………………………………….. 176 Appendix: Dupuytren’s Disease ……………………………………………………………177 Copyright ©2011 - State of Montana 3 July 1, 2011 B. General Guidelines Principles The principles summarized in this section are key to the intended implementation of these guidelines and critical to the reader’s application of the guidelines in this document. 1. APPLICATION OF GUIDELINES The Department provides procedures to implement medical treatment guidelines and to foster communication to resolve disputes among the providers, payers, and patients through the Administrative Rules of Montana. In lieu of more costly litigation, parties may wish to request an independent medical review from the Department's Medical Director prior to submitting a Petition for a Workers’ Compensation Mediation Conference. 2. EDUCATION of the patient and family, as well as the employer, insurer, policy makers and the community should be the primary emphasis in the treatment of upper extremity pain and disability. An education-based paradigm should start with communication providing reassuring information to the patient. A more in-depth education within a treatment regime employing functional restorative and innovative programs of prevention and rehabilitation is optimal. A treatment plan should address issues of individual and/or group patient education as a means of facilitating self-management of symptoms and prevention. 3. TREATMENT PARAMETER DURATION Time frames for specific interventions commence once treatments have been initiated, not on the date of injury. Obviously, duration will be impacted by patient compliance, as well as availability of services. Clinical judgment may substantiate the need to accelerate or decelerate the time frames discussed in this document. 4. ACTIVE INTERVENTIONS emphasizing patient responsibility, such as therapeutic exercise and/or functional treatment, are generally emphasized over passive modalities, especially as treatment progresses. Generally, passive interventions are viewed as a means to facilitate progress in an active rehabilitation program with concomitant attainment of objective functional gains. 5. ACTIVE THERAPEUTIC EXERCISE PROGRAM goals should incorporate patient strength, endurance, flexibility, coordination, and education. This includes functional application in vocational or community settings. 6. FUNCTIONAL IMPROVEMENT GOALS should be consistently addressed. Positive patient response results are defined primarily as functional gains that can be objectively measured. Objective functional gains include, but are not limited to, positional tolerances, range- of-motion (ROM), strength and endurance, activities of daily living, cognition, psychological behavior, and efficiency/velocity measures that can be quantified. Subjective reports of pain and function should be considered and given relative weight when the pain has anatomic and physiologic correlation. Anatomic correlation must be based on objective findings. 7. RE-EVALUATE TREATMENT EVERY 3 TO 4 WEEKS If a given treatment or modality is not producing positive results within 3 to 4 weeks, the treatment should be either modified or discontinued. Reconsideration of diagnosis should also occur in the event of poor response to a Copyright ©2011 - State of Montana 4 July 1, 2011 seemingly rational intervention. 8. SURGICAL INTERVENTIONS should be contemplated within the context of expected functional outcome and not purely for the purpose of pain relief. The concept of “cure” with respect to surgical treatment by itself is generally a misnomer. All operative interventions must be based upon positive correlation of clinical findings, clinical course, and diagnostic tests. A comprehensive assimilation of these factors must lead to a specific diagnosis with positive identification of pathologic condition(s). 9. SIX-MONTH TIME FRAME The prognosis drops precipitously for returning an injured worker to work once he/she has been temporarily totally disabled for more than six months. The emphasis within these guidelines is to move patients along a continuum of care and return to work within a six-month time frame, whenever possible. It is important to note that time frames may not be pertinent to injuries that do not involve work-time loss or are not occupationally related. 10. RETURN-TO-WORK is therapeutic, assuming the work is not likely to aggravate the basic problem or increase long-term pain. The practitioner must provide specific physical limitations and the patient should be released to return to work with specific physical activity limitations clearly spelled out per the specific job requirement. Release to “sedentary” or “light duty” is not a specific physical limitation. The following physical limitations should be considered and modified as recommended: lifting, pushing, pulling, crouching, walking, using stairs, overhead work, bending at the waist, awkward and/or sustained postures, tolerance for sitting or standing, hot and cold environments, data entry and other repetitive motion tasks, sustained grip, tool usage and vibration factors. Even if there is residual chronic pain, return-to-work is not necessarily contraindicated. The practitioner should understand all of the physical demands of the patient’s job position before returning the patient to full
Load more

Recommended publications
  • Sensory Receptors A17 (1)
    SENSORY RECEPTORS A17 (1) Sensory Receptors Last updated: April 20, 2019 Sensory receptors - transducers that convert various forms of energy in environment into action potentials in neurons. sensory receptors may be: a) neurons (distal tip of peripheral axon of sensory neuron) – e.g. in skin receptors. b) specialized cells (that release neurotransmitter and generate action potentials in neurons) – e.g. in complex sense organs (vision, hearing, equilibrium, taste). sensory receptor is often associated with nonneural cells that surround it, forming SENSE ORGAN. to stimulate receptor, stimulus must first pass through intervening tissues (stimulus accession). each receptor is adapted to respond to one particular form of energy at much lower threshold than other receptors respond to this form of energy. adequate (s. appropriate) stimulus - form of energy to which receptor is most sensitive; receptors also can respond to other energy forms, but at much higher thresholds (e.g. adequate stimulus for eye is light; eyeball rubbing will stimulate rods and cones to produce light sensation, but threshold is much higher than in skin pressure receptors). when information about stimulus reaches CNS, it produces: a) reflex response b) conscious sensation c) behavior alteration SENSORY MODALITIES Sensory Modality Receptor Sense Organ CONSCIOUS SENSATIONS Vision Rods & cones Eye Hearing Hair cells Ear (organ of Corti) Smell Olfactory neurons Olfactory mucous membrane Taste Taste receptor cells Taste bud Rotational acceleration Hair cells Ear (semicircular
    [Show full text]
  • Neurolosical Manifestations of Diabetes Mellitus
    1954] MANIFESTATIONS OF DIABETES MELLITUS : VAISHNAVA 463 is the commonest lesion in diabetic neuropathy inal Articles but nerve trunks, spinal ganglia, posterior nerve Orig roots, posterior and lateral columns and ante- rior horn cells of the spinal cord or the motor nuclei of the brain stem, the autonomic ner- Neurological manifestations of vous system and the brain may also be affected. DIABETES MELLITUS The lower extremities appear to bear the greatest brunt of the disease. % HARI P. VAISHNAVA, m.b., b.s. (Lucknow), exact mechanism of these M.R.C.P. (Ed.) The neurological manifestations is not known. As this condi- Medical Registrar and Resident Medical Officer, tion is more common in elderly people, arterio- Victoria Hospital, Blackpool, England sclerosis is considered the most likely cause Neurological complications of diabetes though this theory does not account for its ^ellitug have baffled many physicians. There occurrence in younger people without signs of ]s an extensive American literature on this sub- arterio-sclerosis; moreover, so many elderly ject which is being increasingly recognised in subjects with arterio-sclerosis do not suffer ?ther countries. The incidence of diabetic neu- from neuropathy. r?Pathy varies with different authors, Jordan Martin (1953).states that the condition is a (1936) mentioning 67 per cent; Collens at al degenerative one in which non-myelinated (1952) 93 per cent ; Bonkalo (1950) 49.3 per small calibre fibres degenerate more extensively contrasting with Rundles (1945) 5 per cent. ^eilt, than the larger myelinated ones. The primary *he difference in these figures is mainly due to lesion, according to Martin, is a degeneration lriterpretation of the symptoms; if objective of axis cylinders and sheaths are re- ^gns must be taken into account with the myelin duced as a secondary effect.
    [Show full text]
  • Case Report Endometrial Carcinoma Presenting As Vasculitic Sensorimotor Polyneuropathy
    CORE Metadata, citation and similar papers at core.ac.uk Provided by PubMed Central Hindawi Publishing Corporation Case Reports in Obstetrics and Gynecology Volume 2011, Article ID 968756, 3 pages doi:10.1155/2011/968756 Case Report Endometrial Carcinoma Presenting as Vasculitic Sensorimotor Polyneuropathy Marketa Vasku, Thomas Papathemelis, Nicolai Maass, Ivo Meinhold-Heerlein, and Dirk Bauerschlag Department of Gynecology and Obstetrics, University Medical Center Aachen, Pauwelsstraße 30, 52074 Aachen, Germany Correspondence should be addressed to Marketa Vasku, [email protected] Received 10 May 2011; Accepted 15 June 2011 Academic Editors: S. Z. A. Badawy and S.-Y. Ku Copyright © 2011 Marketa Vasku et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Paraneoplastic syndromes (PNS) are a heterogeneous group of symptoms which are indirectly caused by primary or metastatic tumor. Paraneoplastic polyneuropathy (PNP) is mostly related to small cell lung cancer (5%), prostate, gastric, and breast cancer. Only sporadic cases have been reported to be associated with endometrial cancer. We present a case of a premenopausal woman with severe vasculitic, asymmetric sensorimotor polyneuropathy that developed in conjunction with an endometrial carcinoma responding to surgical therapy of primary tumor combined to steroid therapy. Neurological symptoms such as asymmetrical sensorimotor deficits and painful paresthesias are suspicious when they occur in otherwise healthy women with no medical history. The phenomenon of a paraneoplastic syndrome can point to an underlying malignancy and can be used as marker of progression or regression of the tumor.
    [Show full text]
  • A Current Overview of Diabetic Neuropathy – Mechanisms, Symptoms, Diagnosis, and Treatment
    Chapter 5 A Current Overview of Diabetic Neuropathy – Mechanisms, Symptoms, Diagnosis, and Treatment Takashi Kawano Additional information is available at the end of the chapter http://dx.doi.org/10.5772/58308 1. Introduction Diabetic neuropathies are nerve disorders associated with diabetes, which affect approxi‐ mately half of all diabetes patients [1]. The most common complication of diabetes is caused by hyperglycemia which can damage nerve fibers throughout the body [2]. Depending on the types of nerves involved, diabetic neuropathies can be categorized as peripheral, autonomic, proximal, focal neuropathies [3]. Because the pathogenesis mechanisms of diabetic neuropathy remain unknown, numerous studies try to elucidate the underlying mechanisms of this disease. Several reports have demonstrated that a variety of molecules are likely involved in the development of diabetic neuropathy, such as protein kinase C, polyol, aldose reductase, advanced glycation end- products, reactive oxygen species, cytokines [1-10]. Moreover, some risk factors including metabolite, autoimmune, inherited traits and lifestyle, may contribute to the development of diabetic neuropathy. These multiple factors mentioned above might correlate with various symptoms of diabetic neuropathy. These symptoms vary in different organ systems, such as the extremities, digestive system, urinary tract, blood vessels, heart, and sex organs, depending on the nerves affected [9, 10]. The symptoms usually include pain, foot ulcer, dysesthesia, numbness and tingling of extremities, indigestion, nausea, vomiting, diarrhea, facial and eyelid drooping, eyesight change, dizziness, muscle weakness, dysphagia, urinary incontinence, sexual dysfunction, and speech impairment [2, 4, 9-11] The symptoms remain minor initially and develop gradually over years. As a result, the majority of patients do not even realize they are affected until the complications become noticeable or severe.
    [Show full text]
  • Assessment of Sensory Processing Among People with Neurological Impairment
    Review Article Sports Medicine and Rehabilitation Journal Published: 22 Mar, 2018 Assessment of Sensory Processing Among People with Neurological Impairment Kristina Zdjelar1, Ivana Crnković2*, Aleksandar Racz3 and Ivana Minauf2 1Clinical Hospital Sveti Duh, Croatia 2Department of Physiotherapy, University of Applied Health Sciences Zagreb, Croatia 3Department of Public Health and Health Protection, University of Applied Health Studies Zagreb, Croatia Abstract This paper presents methods of assessing sensory integrative dysfunction in persons with neurological impairments as an indispensable element in physiotherapy intervention. Deterioration of the sensory function causes misinterpretation of stimuli, the inability to learn new patterns of movement, the proper execution of movement, significantly disturbs the quality of life of people with neurological difficulties. By properly evaluating the sensory function, it is possible to identify the sensor problems in detail, defining the objectives and intervention plan, and solving the problem by targeted intervention. Based on preliminary research and available literature on sensory function estimation, the paper presents the role of sensory integration as one of the basic methods of work in the field of physiotherapist work in rehabilitation and habilitation of persons with neurological impairment. Physiotherapists in the rehabilitation of persons with neurological impairments use sensory integration methods to obtain an adequate motor response to sensory input to develop functional motor abilities of the patient. The application of the principle of sensory integration in the work of persons with neurological impairments requires additional education of all health professionals employed in rehabilitation as well as physiotherapists through lifelong learning. Keywords: Sensory function; Neurological impairment; Rehabilitation Introduction OPEN ACCESS Sensory function is one of the most complex and finest of the human body functions.
    [Show full text]
  • Cumulative Trauma Treatment Guidelines
    RULE 17, EXHIBIT 5 Cumulative Trauma Conditions Medical Treatment Guidelines Revised: December 29, 2016 Effective: March 2, 2017 Adopted: November 4, 1996 Effective: December 30, 1996 Revised: January 8, 1998 Effective: March 15, 1998 Revised: May 27, 2003 Effective: July 30, 2003 Revised: September 29, 2005 Effective: January 1, 2006 Revised: September 16, 2010 Effective: October 30, 2010 Presented by: DIVISION OF WORKERS' COMPENSATION TABLE OF CONTENTS A. INTRODUCTION .............................................................................................................................. 1 B. GENERAL GUIDELINES PRINCIPLES .......................................................................................... 2 1. APPLICATION OF THE GUIDELINES ............................................................................... 2 2. EDUCATION ....................................................................................................................... 2 3. INFORMED DECISION MAKING ....................................................................................... 2 4. TREATMENT PARAMETER DURATION ........................................................................... 2 5. ACTIVE INTERVENTIONS ................................................................................................. 3 6. ACTIVE THERAPEUTIC EXERCISE PROGRAM .............................................................. 3 7. POSITIVE PATIENT RESPONSE ...................................................................................... 3 8. RE-EVALUATE
    [Show full text]
  • The Right Thalamic Ventral Posterolateral Nucleus Seems to Be Determinant for Macrosomatognosia: a Case Report Amir H
    ElTarhouni et al. BMC Neurology (2020) 20:393 https://doi.org/10.1186/s12883-020-01970-3 CASE REPORT Open Access The right thalamic ventral posterolateral nucleus seems to be determinant for macrosomatognosia: a case report Amir H. ElTarhouni1, Laura Beer1, Michael Mouthon2, Britt Erni1, Jerome Aellen3, Jean-Marie Annoni2, Ettore Accolla2, Sebastian Dieguez2 and Joelle N. Chabwine1,2* Abstract Background: Macrosomatognosiais the illusory sensation of a substantially enlarged body part. This disorder of the body schema, also called “Alice in wonderland syndrome” is still poorly understood and requires careful documentation and analysis of cases. The patient presented here is unique owing to his unusual macrosomatognosia phenomenology, but also given the unreported localization of his most significant lesion in the right thalamus that allowed consistent anatomo-clinical analysis. Case presentation: This 45-years old man presented mainly with long-lasting and quasi-delusional macrosomatognosia associated to sensory deficits, both involving the left upper-body, in the context of a right thalamic ischemic lesion most presumably located in the ventral posterolateral nucleus. Fine-grained probabilistic and deterministic tractography revealed the most eloquent targets of the lesion projections to be the ipsilateral precuneus, superior parietal lobule,but also the right primary somatosensory cortex and, to a lesser extent, the right primary motor cortex. Under stationary neurorehabilitation, the patient slowly improved his symptoms and could be discharged back home and, later on, partially return to work. Conclusion: We discuss deficient neural processing and integration of sensory inputs within the right ventral posterolateral nucleus lesion as possible mechanisms underlying macrosomatognosia in light of observed anatomo- clinical correlations.
    [Show full text]
  • Physiology of Proprioception in Balance Neuropsychiatry Block
    NeuroPsychiatry Block Physiology of Proprioception in Balance By Laiche Djouhri, PhD Dept. of Physiology Email: [email protected] Ext:71044 NeuroPsychiatry Block Somatic Sensations: I. General Organization, the Tactile and Position Senses Chapter 48 (Guyton & Hall) 2 Objectives By the end of this lecture students are expected to: . Identify the major sensory receptors & pathways . Describe the components, processes and functions of the sensory pathways . Appreciate the dorsal column system in conscious proprioception . Describe the spinocerebellar tract pathway in unconscious proprioception .10Differentiate/9/2016 between sensory and motor ataxia3 What Are Somatic Receptors? . Somatic receptors are sensory receptors that respond to a stimulus in the external environment of the body/organism . They are found in many parts of the body including the skin (cutaneous receptors), skeletal muscles, bones and joints (proprioceptors) . They differ from specific receptors that mediate the special senses of vision, hearing, smell, taste and equilibrium. 4 Classification of Sensory Receptors-1 A. Based on their location (Sherrington 1906) ❶ Exteroceptors: concerned with the external environment • Found on the the surface of the body • Monitor changes in the external environment ❷ Interoceptors: concerned with the internal environment (visceral) ❸ Proprioceptors: concerned with one`s own body position • Are those relating to the physical state of the body, including joint position, and sate of tendons and muscles. 5 Classification of Sensory Receptors-2 B. Based on their adequate stimulus . Mechanoreceptors . Thermoreceptors (cold & heat) . Chemoreceptors (e.g. taste receptors) . Photoreceptors (in the retina). Nociceptors (pain receptors) 6 Classification of Sensory Receptors-3 C. Based on their speed of adaptation . Slowly adapting (SA): fire as long as the stimulus is there (tonic receptors) • Nociceptors and proprioceptors show no or very little adaptation .
    [Show full text]
  • Neurophysiologic Diagnosis, Clinical Symptoms and Neuropathologic Findings in Polyneuropathies
    TURUN YLIOPISTON JULKAISUJA ANNALES UNIVERSITATIS TURKUENSIS SARJA - SER. D OSA - TOM. 849 MEDICA - ODONTOLOGICA NEUROPHYSIOLOGIC DIAGNOSIS, CLINICAL SYMPTOMS AND NEUROPATHOLOGIC FINDINGS IN POLYNEUROPATHIES by Satu Laaksonen TURUN YLIOPISTO Turku 2009 From the Department of Clinical Neurophysiology Turku University Hospital, Turku, Finland SUPERVISED BY Docent Björn Falck, MD Department of Clinical Neurophysiology University of Turku Turku, Finland and Docent Liisa- Maria Voipio-Pulkki, MD The Association of Local and Regional Authorities in Finland and Department of Medicine University of Turku, Turku, Finland REVIEWED BY Docent Aki Hietaharju, MD Department of Neurology Tampere University Hospital, Tampere, Finland and Docent Tapani Salmi, MD Department of Clinical Neurophysiology Helsinki University Hospital, Helsinki, Finland DISSERTATION OPPONENT Professor Juhani Partanen, MD Helsinki University Hospital, Helsinki, Finland ISBN 978-951-29-3924-4 (PRINT) ISBN 978-951-29-3925-1 (PDF) ISSN 0355-9483 Painosalama Oy – Turku, Finland 2009 To my husband Jussi, and our children Stella, Matias and Oliver 4 Abstract ABSTRACT Satu Laaksonen. Neurophysiologic diagnosis, clinical symptoms and neuropathologic findings in polyneuropathies. Department of Clinical Neurophysiology, Turku University Hospital. Annales Universitatis Turkuensis, Medica-Odontologica, Turku, Finland, 2009. Backround: Polyneuropathy (PNP) is a disorder of the peripheral nervous system that causes widespread, usually symmetric, abnormalities of peripheral nerves. Numerous underlying conditions can cause PNP. Aims: To evaluate the subjective PNP symptoms and the most useful neurophysiologic tests for the diagnosis of uremic PNP, thalidomide induced PNP in myeloma patients, and PNP in Fabry disease. Another aspect of the study was to determine the correlation between subjective symptoms and neurophysiologic and neuropathologic findings in patients with PNP.
    [Show full text]
  • Diagnosis of Polyneuropathies Guidelines of the German Society of Neurology
    Guidelines e3 Diagnosis of Polyneuropathies Guidelines of the German Society of Neurology Authors D. Heuß1, M. Auer−Grumbach2, W. F. Haupt3, W. Löscher4, B. Neundörfer5, B. Rautenstrauß6, S. Renaud7, C. Sommer8 Affiliations The affiliations are listed at the end of the article. Keywords Abstract What’s new? l" polyneuropathies ! ! l" definition The most important recommendations at a " Mitofusin−2−(MFN2−)mutations are the most l" manifestation types glance: History and clinical findings provide the common cause of CMT 2 neuropathies (Ver− l" clinical examination most important data for the classification of hoeven et al. 2006) (III) (B). l" differential diagnosis polyneuropathies (familial, acute versus chronic " Antibodies to MAG or SGPG occur frequently l" neurophysiological examination course, concomitant disease; involved organ sys− in patients with IgM amyloidosis but their l" muscle and nerve biopsy tems, symmetrical versus multifocal etc.) (IV) (C). presence alone does not predict occurrence or l" skin biopsy Electrophysiological examination is necessary to type of polyneuropathy (Garces−Sanchez et al. l" genetic testing determine the pattern of distribution and the 2008) (III) (B). l" laboratory tests type of lesion (axonal versus demyelinating) in " Several new or recently established methods order to detect specific patterns of damage (e.g. facilitate the diagnosis of small−fiber neuro− conduction blocks) and to assess the resulting pathy which is not detectable by conventional degree of muscle damage (¹denervation“) (B). electrophysiological methods (Sommer and Laboratory tests should include the most impor− Lauria 2007) (III) (B). tant treatable polyneuropathies (see below) (C). " Ultrasound and MRI examinations are helpful The examination of CSF is useful in the differen− in the diagnosis of neuropathies according to tial diagnosis of inflammatory polyneuropathies preliminary studies (Bendszus and Stoll 2005, (B).
    [Show full text]
  • Sensory Neuronopathy Revealing Severe Vitamin B12 Deficiency in a Patient with Anorexia Nervosa: an Often‐Forgotten Reversible Cause
    Case Report Sensory Neuronopathy Revealing Severe Vitamin B12 Deficiency in a Patient with Anorexia Nervosa: An Often‐Forgotten Reversible Cause Jérôme Franques 1,2, Laurent Chiche 2,* and Stéphane Mathis 3 1 Hôpital de La Casamance, 13400 Aubagne, France; j.franques@hp‐lacasamance.fr 2 Service de Médecine Interne, Hôpital Européen, 13003 Marseille, France 3 Service de Neurologie, CHU Bordeaux 33000 Bordeaux, France; stephane.mathis@chu‐bordeaux.fr * Correspondence: l.chiche@hopital‐europeen.fr; Tel.: +33‐616‐834‐430; Fax: +33‐413‐427‐712 Received: 17 February 2017; Accepted: 13 March 2017; Published: 15 March 2017 Abstract: Vitamin B12 (B12) deficiency is known to be associated with various neurological manifestations. Although central manifestations such as dementia or subacute combined degeneration are the most classic, neurological manifestations also include sensory neuropathies. However, B12 deficiency is still rarely integrated as a potential cause of sensory neuronopathy. Moreover, as many medical conditions can falsely normalize serum B12 levels even in the context of a real B12 deficiency, some cases may easily remain underdiagnosed. We report the illustrating case of an anorexic patient with sensory neuronopathy and consistently normal serum B12 levels. After all classical causes of sensory neuronopathy were ruled out, her clinical and electrophysiological conditions first worsened after folate administration, but finally improved dramatically after B12 administration. B12 deficiency should be systematically part of the etiologic workup of sensory neuronopathy, especially in a high risk context such as anorexia nervosa. Keywords: sensory neuropathy; cobalamin deficiency; vitamin B12; anorexia nervosa 1. Introduction Vitamin B12 (B12) or cobalamin deficiency is a real public health issue, since it has been reported to occur in up to 20% of the elderly and up to 30% in specific subgroups of patients above 70 years [1,2].
    [Show full text]
  • In This Chapter, We Will Examine
    CHAPTER 6 SOMESTHESIA - CENTRAL MECHANISMS n this chapter, we will examine the Magendie, who originally stated that most pathways that somatic activity can take fibers in the ventral roots were motor. Iin the central nervous system, and then we will consider the mechanisms by which different sensations can occur. Somatosensory pathways. Once the primary afferent fibers leave the skin, they group together into larger and larger bundles in the cutaneous nerves. At some point in their course they are joined by muscle nerves, containing sensory and motor fibers of the muscles. Nerves that innervate the skin are termed cutaneous nerves, and those that contain both skin and muscle fibers are termed mixed nerves. The sciatic Figure 6-1. A cross section through the cervical nerve is an example of a mixed nerve. spinal cord showing the entry of the two divisions Nerve fibers that carry impulses to the CNS of the dorsal roots and the routes that fibers take into the major ascending tracts. (Crosby EC, are called afferent; those that carry them Humphrey T, Lauer, EW: Correlative Anatomy of from the CNS are efferent. The afferent the Nervous System. New York, Macmillan, 1962) and efferent fibers are separate from each other at the skin or muscle, but they are The dorsal roots are often divided into two usually mixed together along most of the parts, a lateral division consisting mainly of course of the nerve on the periphery. Near unmyelinated fibers and a medial division the spinal cord, the afferent and efferent consisting mainly of larger, myelinated fibers separate again, the efferent fibers fibers (see Fig.
    [Show full text]